Correlation Between Neurobo Pharmaceuticals and Kiora Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurobo Pharmaceuticals and Kiora Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurobo Pharmaceuticals and Kiora Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurobo Pharmaceuticals and Kiora Pharmaceuticals, you can compare the effects of market volatilities on Neurobo Pharmaceuticals and Kiora Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurobo Pharmaceuticals with a short position of Kiora Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurobo Pharmaceuticals and Kiora Pharmaceuticals.
Diversification Opportunities for Neurobo Pharmaceuticals and Kiora Pharmaceuticals
-0.1 | Correlation Coefficient |
Good diversification
The 3 months correlation between Neurobo and Kiora is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding Neurobo Pharmaceuticals and Kiora Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kiora Pharmaceuticals and Neurobo Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurobo Pharmaceuticals are associated (or correlated) with Kiora Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kiora Pharmaceuticals has no effect on the direction of Neurobo Pharmaceuticals i.e., Neurobo Pharmaceuticals and Kiora Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurobo Pharmaceuticals and Kiora Pharmaceuticals
Given the investment horizon of 90 days Neurobo Pharmaceuticals is expected to generate 0.89 times more return on investment than Kiora Pharmaceuticals. However, Neurobo Pharmaceuticals is 1.13 times less risky than Kiora Pharmaceuticals. It trades about -0.01 of its potential returns per unit of risk. Kiora Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest 648.00 in Neurobo Pharmaceuticals on October 21, 2024 and sell it today you would lose (434.00) from holding Neurobo Pharmaceuticals or give up 66.98% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 98.19% |
Values | Daily Returns |
Neurobo Pharmaceuticals vs. Kiora Pharmaceuticals
Performance |
Timeline |
Neurobo Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Kiora Pharmaceuticals |
Neurobo Pharmaceuticals and Kiora Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurobo Pharmaceuticals and Kiora Pharmaceuticals
The main advantage of trading using opposite Neurobo Pharmaceuticals and Kiora Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurobo Pharmaceuticals position performs unexpectedly, Kiora Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kiora Pharmaceuticals will offset losses from the drop in Kiora Pharmaceuticals' long position.Neurobo Pharmaceuticals vs. Allarity Therapeutics | Neurobo Pharmaceuticals vs. Virax Biolabs Group | Neurobo Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Neurobo Pharmaceuticals vs. Biodexa Pharmaceticals |
Kiora Pharmaceuticals vs. Virax Biolabs Group | Kiora Pharmaceuticals vs. Revelation Biosciences | Kiora Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | Kiora Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Complementary Tools
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |